SOURCE: Gamma Pharmaceuticals Inc.

October 06, 2009 09:56 ET

Gamma Pharmaceuticals Announces Agreement With Evander Holyfield

Las Vegas, NV--(Marketwire - October 6, 2009) - Gamma Pharmaceuticals Inc. (the "Company")(PINKSHEETS: GMPM) announced the Company has signed an Agreement-in-Principal (the "Agreement") with four-time World Heavyweight Champion Evander Holyfield. The Agreement, first made public by Mr. Holyfield at a press conference on September 25, 2009 announcing Holyfield's health and green environmental initiatives, outlines a number of commercial opportunities including the development of the "Holyfield Theory" nutritional supplements and training programs as well as cross promotions and personal appearances with Gamma's own branded products. Gamma will assist Holyfield in the final product definition and formulation and have worldwide marketing and distribution rights. Evander Holyfield is one of the most recognized athletes in the world today. At 46, he is seeking to unify the world heavyweight division. Holyfield's next fight is set for November 8, 2009 in Seoul, South Korea. His training techniques and nutritional program have kept Holyfield in peak physical condition and has made him the envy of his peers. Holyfield with Gamma will define and commercialize his unique brand in the form of vitamins and nutritional supplements and workout programs. The products will be available worldwide through Gamma's global distribution platform.

Peter Cunningham, Gamma's CEO, stated, "We are thrilled to be in business with such an elite global athlete and personality. He truly transcends demographic groups, cultures and boarders and fits our philosophy and company ethos perfectly. He is the "Real Deal" and we aim to make a significant impact with his brand in our marketplace, it's a real knock out for Gamma."

Mr. Holyfield commented, "Gamma came with the right set of ideas and platform to enable me to make a meaningful contribution by commercializing my nutritional philosophy and training ideas and distributing them to the widest market available. I've gained immeasurable knowledge on health and nutrition through my many years of training and I'm really excited to have Gamma in my corner as we bring the products to market."

About Evander Holyfield

Evander Holyfield is a professional boxer from the United States and is the only 4-time World Heavyweight Champion earning him the nickname "The Real Deal". He is one of the most recognized athletes in the world. Outside of boxing, he has appeared in numerous Television shows and movies including a 5th place finish in 2005 on ABC's Dancing with the Stars. He is the President of the Holyfield Foundation, created to help disadvantaged young people become healthy, successful and productive adults. The Holyfield Foundation strives to strengthen the lives of youth and their families by establishing and funding programs dedicated to their athletic, academic and spiritual development.

About Gamma Pharmaceuticals Inc

Gamma Pharmaceuticals Inc. ( is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in Greater China and the United States. Branded nutritional supplements are sold under the trademarks Brilliant Choice™ children's nutritional supplements featuring the call to action "Mom you've made a brilliant choice for you children's nutrition;" SAVVY™ adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthhy;" and, Jugular Energy Products™ and high performance supplements featuring the call to action, "Go for the Jugular™." Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma's product sales and retail partners.

At present Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize proprietary "Gel Delivery Technology®", to create innovative gel product forms; that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms, and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKU's and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact Information